GH · Categories · Downgrades
GH - Analyst downgrades
Guardant Health Inc. (GH) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for GH
- Guardant Health downgraded by Evercore ISI with a new price targetEvercore ISI downgraded Guardant Health from Outperform to In-line and set a new price target of $105.00
- Guardant Health downgraded by Citigroup with a new price targetCitigroup downgraded Guardant Health from Buy to Neutral and set a new price target of $33.00 from $60.00 previously
- Guardant Health downgraded by Piper Sandler with a new price targetPiper Sandler downgraded Guardant Health from Overweight to Neutral and set a new price target of $50.00 from $65.00 previously